Janssen CAR-T is Priority Medicine in EU, and moreEuropean regulators are to hasten development of Janssen’s CAR-T therapy for patients with multiple myeloma, after promising early-stage Share XJanssen CAR-T is Priority Medicine in EU, and morehttps://pharmaphorum.com/views-analysis-oncology/janssen-car-t-is-priority-medicine-in-eu-and-more/
Tesaro stock rockets as rumours of Roche takeover aboundShares in US biotech Tesaro peaked this week amid speculation that Roche is making plans to buy it. Share XTesaro stock rockets as rumours of Roche takeover aboundhttps://pharmaphorum.com/news/tesaro-stock-rockets-roche-takeover-abound/
